← Home / Medtronic plc (MDT)
Stock Analysis
Medtronic plc (MDT)
MDT
MDT · Healthcare • Medical Devices
85.39 -0.37%
Track MDT in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when MDT price is:
52W Range Position
37%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-31 23:52 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 86.73. Holding above 82.36 keeps the current thesis intact.
⚖️
✓
Fundamentals
Improving / Improving
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
82.36
↗
Break Above
Confirmation improves above resistance.
86.73
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 82.36
Recent Company Events
SEC VERIFIED
Latest material filings
JUN
3
●
Financial Results
HIGH
Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2026 (FY26), which ended April 24, 2026.
8-K Filing • SEC EDGAR
MAY
18
●
Management / Board
MEDIUM
MDT board and management update
Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.
8-K Filing • SEC EDGAR
What's Driving MDT?
📈 Technical recovery is improving
Momentum is Neutral. Watch 86.73 for confirmation and 82.36 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 82.36
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
103.30
Invalidation
103.30
RSI(14)
58.0
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 82.36 and resistance around 86.73. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
MDT — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Value
Value-oriented setup
Sales and book multiples are contained.
Market Cap
$109.6B
Company size
EV
$133.4B
Debt-adjusted value
P/E
22.7
Reasonable
P/S
3.0
Low sales multiple
P/B
2.2
Balanced
EV/Sales
3.7
Low sales multiple
EV/EBIT
20.6
Reasonable
P/FCF
20.2
Reasonable
FCF Yield
4.95%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving financial execution
Revenue and profitability remain supportive, while cash flow and balance sheet quality require monitoring.
↗
Revenue Growth
Improving
●
Profitability
Improving
≈
Cash Flow
Healthy
⚖
Balance Sheet
Manageable
💵 Revenue
9.02B
↗ Improving
📈 Net Income
1.15B
↗ Improving
🧮 EPS (Basic)
0.89
↗ Improving
Medtronic plc
Healthcare • Medical Devices
Related Opportunities